(MedPage Today) — Note that some links may require registration or subscription.
The BMJ retracted a phase III clinical trial of stem cells to prevent acute myocardial infarction induced heart failure amid ongoing concerns about data integrity…
Source:
www.medpagetoday.com
Medical Disclaimer:
This content is shared for informational and educational purposes only.
It does not constitute medical, legal, or policy advice.
Healthcare decisions should always be made in consultation with qualified professionals.
